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Abstract
Aims: Recent reports suggest that iron deficiency impacts both intestinal calcium and phosphate 
absorption, although the exact transport pathways and intestinal segment responsible have not 
been determined. Therefore, we aimed to systematically investigate the impact of iron deficiency 
on the cellular mechanisms of transcellular and paracellular calcium and phosphate transport in 
different regions of the rat small intestine. 
Methods: Adult, male Sprague-Dawley rats were maintained on a control or iron deficient diet for 
two weeks and changes in intestinal calcium and phosphate uptake were determined using the in 
situ intestinal loop technique. The circulating levels of the hormonal regulators of calcium and 
phosphate were determined by ELISA, while the expression of transcellular calcium and 
phosphate transporters, and intestinal claudins were determined using qPCR and western 
blotting. 
Results: Diet-induced iron deficiency significantly increased calcium absorption in the duodenum 
but had no impact in the jejunum and ileum. In contrast, phosphate absorption was significantly 
inhibited in the duodenum and to a lesser extent the jejunum, but remained unchanged in the 
ileum. The changes in duodenal calcium and phosphate absorption in the iron deficient animals 
were associated with increased claudin 2 and 3 mRNA and protein levels, while levels of 
parathyroid hormone, fibroblast growth factor-23 and 1,25-dihydroxy vitamin D3 were unchanged. 
Conclusion: We propose that iron deficiency alters calcium and phosphate transport in the 
duodenum. This occurs via changes to the paracellular pathway, whereby upregulation of claudin 
2 increases calcium absorption and upregulation of claudin 3 inhibits phosphate absorption. 
Keywords: Calcium, Claudin, Intestine, Iron deficiency, Paracellular, Phosphate
Introduction
The regulation of systemic iron homeostasis is essential for many biological processes, including 
the formation of the oxygen transport proteins, haemoglobin and myoglobin, and for the catalytic 
activity of many enzymes in the body. Systemic iron homeostasis is controlled by the peptide 
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the basolateral iron transporter ferroportin1,2 and the apical divalent metal transporter type 1 
(DMT1).3 Recent evidence suggests that hepcidin also affects intestinal calcium transport4,5 and 
that iron deficiency may be a risk factor for the development of osteoporosis.6 Given that calcium 
and phosphate are key constituents of the bone mineral hydroxyapatite,7 it is possible that the 
absorption of these minerals in the small intestine might also be affected by iron deficiency. In 
keeping with this hypothesis, a limited number of studies have investigated the impact of iron 
deficiency on intestinal calcium and phosphate absorption. Phosphate absorption has been 
shown to increase8 in response to iron deficiency, while calcium absorption has been reported to 
both increase8 and decrease.9 The discrepancy in these findings may be due to inconsistencies in 
the iron composition of the diets and the length of treatment, resulting in differences in the 
severity of iron deficiency. Importantly, no single study has been designed to determine 
systematically the impact of iron deficiency on the different transport pathways and cellular 
mechanisms involved in calcium and phosphate absorption in different regions of the small 
intestine.
Intestinal calcium and phosphate absorption occurs by both transcellular and paracellular 
mechanisms.10,11 The traditional model for transcellular calcium absorption is a three-step 
process involving calcium entry at the apical membrane via the transient receptor potential 
vallinoid 6 (TRPV6) channel,12,13 intracellular shuttling of calcium by calbindin D9k,14,15 and 
basolateral membrane exit of calcium via the plasma membrane calcium ATPase 1b (PMCA-1b) 
and the sodium-calcium exchanger 1 (NCX-1).16,17 Less is known about the overall cellular 
processes responsible for transcellular phosphate transport, with the exception that it is critically 
dependent on the apical type II sodium-dependent phosphate co-transporter, NaPi-IIb.18,19 
Transcellular calcium and phosphate absorption occurs in different regions of the small intestine: 
transcellular calcium transport occurring predominantly in the duodenum,20 while the jejunum is 
the major site for transcellular phosphate absorption,21,22 at least in the rat. In contrast, absorption 
of calcium and phosphate via the paracellular pathway occurs in all three segments of the small 
intestine,20,23,24 and is likely to be the dominant route for absorption under normal or high levels of 
dietary calcium and phosphate intake.25,26  
Paracellular absorption of solutes and ions from the intestinal lumen into the circulation is 
influenced by the composition and architectural organization of tight junction complexes. 
Numerous integral membrane proteins and scaffold proteins combine to form tight junctions, but it 
is recognized that the claudin protein family plays a key role in the transport function of these 
complexes (reviewed in27). Claudins are known to form either epithelial barriers (sealing claudins) 
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profiles along the intestine.28,29 For example, claudin 3, a major sealing claudin that has recently 
been associated with paracellular phosphate absorption,30 and has been demonstrated to be 
most highly expressed in the duodenum.28 While the pore-forming claudins 2 and 12, which have 
a high conductance for calcium, are most abundantly expressed in the jejunum and ileum of 
rats.28,31 While it is widely recognised that 1,25-dihydroxy vitamin D3 (1,25(OH)2D3) is responsible 
for regulating transepithelial calcium and phosphate absorption,32,33 evidence also suggests that it 
increases claudin 2 and 12 proteins levels in a vitamin D receptor (VDR)-dependent manner to 
enhance paracellular calcium absorption.34 Intriguingly, the VDR agonist lithocholic acid (LCA) 
has recently been proposed to supress claudin 3 levels, resulting in increased phosphate 
permeability in the small intestine.30 Based on our growing understanding of the processes 
involved in calcium and phosphate absorption, and the potential that dietary iron deficiency alters 
the intestinal handling of these ions, the current study aimed to investigate the impact of iron 
deficiency on the cellular mechanisms of calcium and phosphate transport in different regions of 
the rat small intestine.
Results
Diet-induced iron deficiency impacts intestinal phosphate and calcium absorption 
Rats administered a diet containing 2-6 ppm of iron had the typical features of iron deficiency, 
including significantly decreased serum iron, plasma ferritin and hematocrit levels, and 
significantly increased UIBC (Table 1). The final weight of the animals after the 2-week dietary 
regime was similar in both groups (Table 1). Additionally, the animals exhibited the expected 
intestinal adaptation to dietary iron deficiency by significantly elevating DMT1 mRNA and protein 
levels in the duodenum (Figure 1). 
Using the in situ intestinal loop technique and 10 mM phosphate in the uptake buffer, diet-
induced iron deficiency was shown to significantly inhibit total transepithelial phosphate 
absorption in the duodenum and jejunum (Figure 2A and 2B) but remained unchanged in the 
ileum (Figure 2C). However, this inhibition was more prominent in the duodenum (Figure 2A) 
compared with the jejunum (Figure 2B). Using the same technique and with 100 mM calcium in 
the uptake solution, total transepithelial calcium absorption was significantly higher in the 
duodenum of iron deficient animals compared with control animals (Figure 2C) but remained 
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phosphate and calcium absorption did not, however, significantly impact serum levels or urinary 
excretion of these two ions (Table 2).  
Effect of diet-induced iron deficiency on the levels of transcellular phosphate and calcium 
transporters
RT-PCR and western blotting experiments were performed to test if there were any changes in 
the mRNA and protein levels of the major transcellular phosphate and calcium transporters in 
response to diet-induced iron deficiency. In the duodenum, NaPi-IIb mRNA levels were 
significantly downregulated in iron deficient animals (Figure 3A). However, the very low levels of 
duodenal NaPi-IIb mRNA (~10-fold lower than jejunum) (Figure 3A), and the lack of detectable 
NaPi-IIb protein in this segment (Figure 3B), raises the question of whether there is any 
physiological relevance of this downregulation for intestinal phosphate absorption. In contrast, 
NaPi-IIb mRNA (Figure 3A) and protein levels (Figure 3C) were unchanged in the jejunum in 
response to iron deficiency. As expected,21,32 NaPi-IIb mRNA levels were undetectable in the 
ileum (results not shown).
In keeping with previous studies, the segmental expression profile of TRPV6, Calbindin D9k and 
PMCA-1b showed a clear distinction, with the highest levels seen in the duodenum (Figure 4A-
C).20 While TRPV6 (Figure 4A) and NCX-1 (Figure 4D) expression was unaffected by iron 
deficiency, a significant decrease in duodenal calbindin D9k (Figure 4B) and jejunal PMCA-1b 
(Figure 4C) gene expression was observed. Because transcellular calcium transport occurs 
mainly in the duodenum, western blotting was used to investigate whether iron deficiency impacts 
the protein levels of the transcellular calcium transporters in this region. The results showed that 
duodenal calbindin D9k protein was significantly downregulated in response to iron deficiency 
(Figure 5B), while TRPV6, PMCA-1b and NCX-1 protein levels were unchanged (Figure 5A, 5C 
and 5D). The downregulation of calbindin D9k mRNA and protein levels as well as the 
unchanged levels of the other transcellular calcium transporters in the duodenum, suggest that 
the transcellular calcium transport pathway does not contribute to the increase in duodenal 
calcium absorption observed in the iron deficient animals.
Diet-induced iron deficiency increases duodenal claudin 2 and 3 levels
Given that previous uptake studies using 10 mM KH2PO422 and 100 mM CaCl220 in the uptake 
buffer demonstrated that paracellular absorption is predominant under these conditions and that 
claudins are likely to be involved in the regulation of paracellular absorption, we used RT-PCR to 









This article is protected by copyright. All rights reserved
demonstrated that diet-induced iron deficiency significantly upregulated claudin 2 and 3 gene 
expression, but only in the duodenum (Figure 6A and B). In contrast, mRNA levels of the other 
highly expressed intestinal claudins 4, 7, 12 and 15, consistently reported in the small intestine of 
rodents,28,31,35 were unaffected by iron deficiency (Figure 6A-F). Western blotting also revealed 
that duodenal claudin 2 and 3 protein levels were significantly upregulated by diet-induced iron 
deficiency, confirming that increased mRNA levels translated to elevated claudin 2 and 3 protein 
in our model (Figure 7A and 8A). 
Furthermore, while 1,25(OH)2D3-VDR interaction plays a major role in regulating claudin 2 
expression and paracellular calcium transport, VDR-dependent regulation of claudin 3 expression 
has been linked recently to changes in paracellular phosphate absorption in the small intestine.30 
To investigate whether the increases in duodenal claudin 2 and 3 mRNA and protein levels in iron 
deficiency were due to any changes in circulating levels of 1,25(OH)2D3 or its regulators, FGF-23 
and PTH, the levels of these hormones were measured by ELISA. The results show that diet-
induced iron deficiency had no effect on the levels of these hormones (Table 2), suggesting that 
they do not contribute to the altered calcium and phosphate absorption seen in iron deficiency.
Discussion 
Previous studies of the effect of iron deficiency on intestinal calcium and phosphate absorption 
have used models of long-term nutritional ferropenic anaemia and have established changes in 
absorption based on the measurement of dietary intake and subsequent faecal excretion.8,9 While 
these studies used Wistar rats and started the dietary treatment immediately after weaning, the 
treatment period (and therefore the severity of iron deficiency) appears to have differing effects 
on calcium handling, with 28 days of treatment decreasing and 40 days increasing apparent 
intestinal calcium absorption. Importantly, these studies describe the sum of absorption and 
secretion of these ions across the small intestine and colon, but do not provide information on 
which intestinal segments are involved in these processes. In the current study, we have used 
the in situ intestinal loop technique to measure transepithelial absorption of phosphate and 
calcium in specific intestinal segments in real time. Contrary to the suggestion that iron deficiency 
may increase intestinal phosphate absorption,8 using a more focused approach, our findings 
show that it significantly blunts phosphate absorption in the duodenum and to a lesser extent the 
jejunum. Interestingly, the impact of iron deficiency on intestinal calcium handling is also localised 
to the duodenum, resulting in enhanced transepithelial calcium absorption in this segment. While 
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these discrepancies arise from differences in the time-scale and severity of the iron deficiency. 
Our study used 6–7-week-old rats fed an iron deficient diet for only 14 days as against the 
published studies that used 3- week-old rats treated for 28 or 40 days. In keeping with this 
suggestion is the finding by Campos et al that the critical period in the evolution of nutritional 
ferropenic anaemia is between 30 - 40 days, and it was at this later time-point that they found 
increased intestinal calcium and phosphate absorption. This increase in absorption was 
associated with an increase in urinary excretion of these ions to maintain serum levels. In our 
study the alteration we observed in duodenal absorption did not impact serum calcium or 
phosphate levels and did not change net urinary excretion, a measure that is commonly used to 
reflect net intestinal absorption.36 Thus, the relatively mild dietary iron deficiency in our model is 
not comparable with severe longer-term nutritional anaemia. In addition, while mild iron deficiency 
causes localised changes in duodenal calcium and phosphate handling, the relatively short length 
and rapid transit time of this segment37 may mean that these changes do not impact overall 
balance of these ions. Alternatively, given that the colon has the capacity for calcium11 and 
phosphate22,24 transport, it is possible that this intestinal segment adapts to the altered duodenal 
absorption to maintain homeostasis. Importantly, although early studies showed that the colon 
has the capacity for both transcellular and paracellular calcium absorption and secretion,38,39 the 
role of the colon in phosphate handling and the mechanisms involved have not been studied in 
detail.  
However, what our results do highlight is a potentially novel mechanism linking iron absorption to 
the regulation of paracellular calcium and phosphate absorption. In this context, it has been 
speculated previously that the formation of complexes between these ions reduces their 
bioavailability and therefore rates of absorption. For example, high oral calcium intake has been 
suggested to interfere with iron absorption; negatively charged molecules such as phytate, the 
principle storage form of phosphorous in plants and seeds, appears to complex with calcium and 
iron to reduce their bioavailability, and phosphate binders commonly contain calcium or iron.40,41 
However, these interactions occur within the intestinal lumen and have the potential to impact 
absorption throughout the small intestine. In contrast, in the present study, changes in absorption 
are confined to the duodenum, the region where iron transport occurs predominantly,42 
suggesting a direct effect of altered iron absorption on the cellular mechanisms involved in 
phosphate and calcium absorption. 
To investigate this aspect further, we focused on the impact of iron deficiency on the key proteins 
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the small intestine. This pathway has been extensively studied for both ions and undergoes 
significant regulation, making it a plausible candidate for the observed changes in intestinal 
transport.  NaPi-IIb is widely considered to be the rate-limiting step for transcellular phosphate 
absorption and the results of the current study, together with previous findings using gene chip 
analysis and quantitative PCR,43,44 show that in response to diet-induced iron deficiency NaPi-IIb 
gene levels are downregulated in the rat duodenum. However, our findings of very low 
expression of NaPi-IIb mRNA and undetectable protein levels in this intestinal segment provide 
evidence that the inhibition of duodenal phosphate absorption by iron deficiency is unlikely to be 
dependent on NaPi-IIb-mediated transcellular transport. Similarly, if alterations in the key cellular 
components described for active transcellular calcium absorption were responsible for the 
enhanced duodenal calcium absorption, an increase in one or more of these proteins would be 
expected.40 We show that the mRNA and protein levels of the components involved in apical or 
basolateral calcium flux are unchanged and that there is a significant reduction in calbindin D9k 
levels. These findings make it unlikely that this pathway is responsible for the increase in 
duodenal calcium absorption seen in iron deficient rats. 
Instead, our results provide evidence for the involvement of the paracellular pathway in the 
altered duodenal calcium and phosphate handling. We specifically selected an uptake buffer 
containing these ions in the millimolar range to allow us to investigate the impact of iron 
deficiency on the paracellular component of absorption, since the transcellular pathway for these 
ions is expected to be saturated at these concentrations.45–47 Our reasoning being that 
paracellular absorption is likely to be the dominant route under normal or high levels of dietary 
calcium and phosphate intake.25,26 Based on these assumptions and the lack of changes in the 
transcellular components of absorption, we investigated whether the specific claudins thought to 
be involved in paracellular calcium and phosphate absorption were altered in iron deficient rats. 
Our results show that iron deficiency elevated levels of claudin 2 and claudin 3 mRNA and 
protein, and that these changes were confined to the duodenum, the region where we 
demonstrated altered rates of absorption. Importantly, there is growing evidence linking claudin 2 
with paracellular calcium transport in both the kidney and small intestine (reviewed in37,48). This 
protein has negatively charged amino acids in the extracellular domains that project into the 
paracellular space to form a tight junction pore, which confers charge selectivity.49,50 Upregulated 
claudin 2 expression and high luminal calcium levels should favour conductance of the cation 
across the paracellular space. This has been confirmed by Fujita et al who demonstrated that 
overexpression or siRNA knockdown of claudin 2 in the intestinal epithelial caco-2 cell line 
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with 1,25(OH)2D3 increased claudin 2 mRNA and protein levels and subsequent knockdown of 
claudin 2 resulted in a significant decrease in 1,25(OH)2D3-induced calcium permeability.34 
Therefore, based on these earlier findings, the upregulation of claudin 2 mRNA and protein levels 
demonstrated in the current study is the most likely contributor to the increase in duodenal 
calcium absorption seen in response to iron deficiency. However, it should be noted that while a 
recent study by Curry et al established that claudin 2 knockout mice have a decrease in passive 
calcium permeability, this adaptation is confined to the colon, where under normal physiological 
conditions the protein is likely to mediate calcium secretion.51 Whether differences in the regional 
profile of claudin 2 in rats versus mice, combined with the local environment in which the protein 
is maximally expressed, impacts the absorptive or secretory function of this protein requires 
further investigation. In contrast to our understanding of the role of claudins in paracellular 
calcium absorption, until recently little has been known on whether claudin(s) are also involved in 
the regulation of paracellular phosphate transport. However, a recent study has shown that 
phosphate, but not calcium, absorption in the jejunum and ileum of claudin 3 knockout mice is 
significantly increased, suggesting that this sealing claudin plays a role in paracellular phosphate 
absorption.30 In keeping with this suggestion, our study shows that the substantial inhibition of 
phosphate absorption in the duodenum is associated with upregulation of claudin 3 mRNA and 
protein levels, while in the jejunum, where diet-induced iron deficiency had only a minor impact 
on phosphate absorption, claudin 3 remained unchanged. 
Since the levels of claudin 2 and 3 have been reported to be sensitive to circulating levels of 
1,25(OH)2D334,52 and activation of VDR by lithocholic acid impacts paracellular phosphate 
absorption via a reduction in claudin 3 levels,30 we investigated whether changes in 1,25(OH)2D3 
were responsible for the altered calcium and phosphate absorption seen in iron deficiency. The 
finding that iron deficiency had no effect on 1,25(OH)2D3 or its regulators, PTH and FGF-23, 
suggest that upregulation of duodenal claudin 2 and 3 observed in the current study was not due 
to changes in the levels of these hormones. Instead, we speculate that changes in claudin 2 and 
3 in iron deficiency may be directly related to a decrease in intracellular pH in duodenal 
enterocytes as a result of the increased iron absorption seen in this segment.53
In summary, the present study investigated the effect of diet-induced iron deficiency on calcium 
and phosphate absorption in the small intestine of male, adult rats. Because the consumption of 
high levels of calcium and phosphate from dairy products and processed food is increasingly 
common, we used uptake buffers containing these ions at concentrations intended to mimic 
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induced iron deficiency increases calcium absorption and inhibits phosphate absorption in the rat 
duodenum by mechanisms that involve changes in the paracellular pathway. We propose that in 
iron deficient rats, upregulation of duodenal claudin 2, a cation-selective pore forming protein, is 
responsible for the increase in calcium absorption, while increased levels of duodenal claudin 3, a 
sealing protein, results in the inhibition of phosphate absorption. 
Materials and methods
Animals and diets
Male 5-6 week old Sprague-Dawley rats (180–200 g) were purchased from Charles River 
Laboratories (Harlow, UK). Rats were either fed a control iron diet (TD. 80394) containing 48 ppm 
added iron or an iron deficient diet (TD. 80396) containing approximately 2-6 ppm added iron for 
2 weeks. Other than the iron content, both diets had the same composition, and contained 0.6% 
phosphate. All diets were purchased from Harlan Laboratories, Inc. Madison, WI, USA. A 
maximum of three rats were housed in the same cage on a 12-hour light/dark cycle, with free 
access to food and water. For urine collection following the 2-week period of diet administration, 
animals were individually housed in metabolic cages for 16 hours. All procedures were approved 
by University College London (Royal Free Campus) Comparative Biology Unit Animal Welfare 
and Ethical Review Body (AWERB) committee and conducted in accordance with the UK 
legislation (Animal Scientific Procedures act, 1986, Amendment regulations 2012). 
In situ intestinal phosphate and calcium uptake experiments 
In situ intestinal loop experiments were carried out as described previously55. In brief, animals 
were anaesthetised by an intraperitoneal injection of 45 mg/kg pentobarbitone sodium (Pentoject; 
Animal care Ltd, UK) and the depth of anaesthesia was confirmed and monitored by checking the 
reflexes (corneal, tail pinch and pedal withdrawal). Phosphate or calcium uptake solution (500 µl) 
was instilled into a 5-cm long segment of cannulated duodenum (approximately 2 cm from the 
pylorus), jejunum (approximately 5 cm from the ligament of Trietz) or ileum (approximately 5 cm 
proximal to the cecum). For phosphate uptake experiments, uptake solution containing 16 mM 
sodium-HEPES, 140 mM NaCl, 3.5 mM KCl and 10 mM KH2PO4 (pH 7.4) and 0.37 MBq 33P 
(PerkinElmer, Bucks, UK) was instilled into the lumen of the cannulated intestinal segment and 
immediately tied off. Calcium uptakes used a similar uptake solution, but with the phosphate 
replaced with 100 mM CaCl2 and 0.37 MBq 45Ca (PerkinElmer, Bucks, UK). Blood (~500 µl) was 









This article is protected by copyright. All rights reserved
solution. After 30 minutes, the intestinal segment was removed, blotted and the length was 
measured and recorded.  The remaining intestinal segments were removed for use in western 
blotting or qPCR and the animal exsanguinated via cardiac puncture, with death ensured by 
incising the heart. The amount of phosphate or calcium transferred from the intestinal segment 
into 1 ml of plasma was calculated using data obtained from scintillation counting (Tri-Carb 
2900TR; Perkin Elmer) of plasma and the initial uptake solution. 
Blood and urine biochemistry
Blood samples were collected at the end of the experiment by cardiac puncture and haematocrit 
measured using a micro-haematocrit reader. Blood was centrifuged at 1500 g for 15 minutes at 4 
°C to obtain serum or plasma, and serum samples were sent to the Chemical Pathology 
Department in the Royal Free Hospital for the measurement of serum iron. All other assays were 
carried out following manufacturer’s instructions. Serum unsaturated iron-binding capacity (UIBC) 
was measured using a commercially available kit (Pointe Scientific Inc., Canton, MI, USA) and 
plasma ferritin was measured using a rat-specific ELISA kit (Abcam, Cambridge, UK). Serum and 
urine phosphate and calcium levels were measured using colorimetric phosphate (Biovision Inc., 
CA, USA) or calcium (GeneTex, CA, USA) assay kits, and urinary creatinine levels determined 
using the Jaffe method.56 Serum intact fibroblast growth factor-23 (iFGF-23) (Kainos Laboratories 
Inc., Tokyo, Japan), C-terminal FGF-23 (cFGF-23) (Immutopics, Inc., San Clemente, CA, USA), 
1,25(OH)2D3 (LSBio Inc., Seattle, WA, USA) and plasma intact parathyroid hormone (PTH) 
(Immutopics, Inc., San Clemente, CA, USA) were also measured by ELISA.
Brush border membrane vesicle preparation
After opening the duodenum, jejunum and ileum longitudinally, mucosa was scraped off using 
glass slides. The mucosa was then snap frozen and stored at -80°C until use. Intestinal brush 
border membrane (BBM) vesicles were subsequently prepared using the MgCl2 precipitation 
method as described previously.32 The protein concentration of BBM vesicles isolated from all 
three intestinal segment was determined using a Bradford assay.57 To validate the purity of the 
BBM vesicles, alkaline phosphatase levels in the initial homogenate and the BBM vesicles was 
measured using the method of Forstner et al.58 The BBM vesicles were approximately 10-fold 
enriched. All the steps in the isolation of the BBM vesicles were carried out at 4°C.
Western blotting
Intestinal BBM vesicles or homogenate (20-50 µg protein) were mixed with laemmli sample buffer 
and separated on either a 10% or a 16% SDS – polyacrylamide gel (depending on the molecular 
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(PVDF) membrane by electroblotting at 15 V for 75 minutes (for proteins with a size above 30 
kDa) or 10 V for 20 minutes (for proteins with a size below 30 kDa). The PVDF membranes were 
then blocked with 6% fat free milk in PBS containing 0.1% Tween 20 (PBS-T), for 1 hour at room 
temperature, after which they were incubated with NaPi-IIb, DMT1, TRPV6, Calbindin D9k, 
PMCA-1b, NCX-1, claudin 2 or 3 antibodies (See Supplementary Table 1 for supplier information 
and dilutions) for 16 hours at 4°C. The membranes were then washed with PBS-T four times (1 x 
for 15 minutes and 3 x for 5 minutes each) and then incubated with an anti-mouse (1:5000 
dilution, Sigma Ltd, Amersham, UK) or anti-rabbit antibody conjugated to horseradish peroxidase 
(1:2000 dilution, GE Healthcare, Buckinghamshire, UK) for 1 hour at room temperature. The 
membranes were washed with PBS-T as described above and the bound antibodies were 
visualised by enhanced chemiluminescence using a Flour-S Multi-Imager System (Biorad, 
Hemmel Hempstead, UK) or a c600 azure imager (Azure Biosystems, Inc., San Francisco, CA, 
USA), with an acquisition time of 3 minutes. Due to sample number (n=5-6) for each group, 
quantitative comparison between samples run on two gels was required.  These gels were 
processed in parallel and each was loaded with an equal number of control and iron-deficient 
samples. The membranes were stripped of the antibodies using Restore™ western blot stripping 
buffer (Thermo Scientific, Hemmel Hempstead, UK) and non-specific protein binding was blocked 
with PBS-T containing 6% fat free milk as described above. The membranes were then incubated 
with a mouse monoclonal antibody raised against β-actin (Supplementary Table 1) for 1 hour at 
room temperature. The membranes were washed and re-incubated with an anti-mouse 
secondary antibody (1:5000 dilution, Sigma Ltd, Amersham, UK) for 1 hour at room temperature 
and then visualized. Densitometric analysis was performed using the Flour-S Multi-Imager 
software or imageJ and the ratio of the protein of interest to β-actin band density was calculated 
for each sample and presented as arbitrary units (a.u). The molecular weight of each protein was 
calculated using the AzureSpot analysis software.
Quantitative PCR
Total RNA was isolated from the scraped duodenal, jejunal and ileal mucosa using TRIzol™ 
reagent according to manufacturer’s instructions (Life Technologies, Paisley, UK). 1 µg RNA was 
treated with deoxyribonuclease I (Life Technologies, Paisley, UK) and complementary DNA 
(cDNA) was synthesised by reverse transcription using a cDNA synthesis kit (PCR Biosystems 
Ltd, London, UK), following manufacturer's instructions. The expression levels of the genes of 
interest were analysed by real-time quantitative PCR (RT-PCR) using qPCRBIO SyGreen kit 
(PCR Biosystems Ltd, London, UK) and rat specific primers (Supplementary Table 2) purchased 









This article is protected by copyright. All rights reserved
cycling conditions were as follows: preincubation at 95°C for 10 minutes, 3-step amplification 
consisting of: 95°C for 10 seconds, 60°C for 10 seconds and 72°C for 10 seconds. A total of 35 or 
45 cycles depending on the level of gene expression were carried out followed by a melting step 
consisting of 95°C for 10 seconds, 60°C for 60 seconds and 97°C for 1 second. The final 
condition of the melting stage was continuous with five readings recorded per unit temperature. 
The data was analysed using the Light Cycler 96 analysis software and the relative quantification 
(Rel Quant) of the mRNA for each gene of interest relative to β-actin was determined.
Statistical analysis
Data are presented as mean ± standard error of mean (SEM). Statistical analysis was performed 
using either an unpaired Student’s t-test, one-way ANOVA or a two-way ANOVA, with Tukey 
multiple comparisons post-hoc test where relevant. All analyses were performed using GraphPad 
Prism 8 software, and statistical significance depicted as *P < 0.05, **P < 0.01, ***P < 0.001 or 
****P < 0.0001.
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Table and Figure Legends
Table 1: Effect of diet-induced iron deficiency on markers of iron status and animal weight. 
Data is presented as mean ± SEM and analysed using an unpaired t-test. Haematocrit 
(***P<0.001, n=12), serum iron (***P<0.001, n=5-6), serum UIBC, (****P<0.0001, n=8-9), plasma 
ferritin (*P<0.05, n=4-5) and weight of animals (n=12). 
Table 2: Effect of diet-induced iron deficiency on serum phosphate and calcium levels, 
urinary phosphate and calcium excretion and systemic regulators of these ions. Data is 
presented as mean ± SEM and analysed using an unpaired t-test. Serum phosphate (n=6), 
serum calcium (n=11-12), urinary phosphate to creatine ratio and net urinary phosphate excretion 
(n=4-5), urinary calcium to creatine ratio and net urinary calcium excretion (n=9-10), serum iFGF-
23 (n=7), serum cFGF-23 (n=6), plasma intact PTH (n=10-11), and serum 1,25(OH)2D3 (n=6).
Figure 1: DMT1 mRNA and protein levels are increased in the duodenum by diet-induced 
iron deficiency. The effect of iron deficiency on duodenal DMT1 mRNA expression (A) was 
quantified using qPCR. Duplicate PCR reactions were performed for each sample and the mRNA 
expression of DMT1 given relative to β-actin mRNA levels. The effect of iron deficiency on 
duodenal DMT1 protein levels (B) was quantified by western blotting of BBM vesicles prepared 
from the intestine of control and iron deficient animals. The bar graph shows the density of DMT1 
relative to β-actin. An unpaired t-test was used to compare the differences between control and 
iron deficient groups for both mRNA and protein levels (*P<0.05, **** P<0.0001, n=6-10).
Figure 2: Diet-induced iron deficiency impacts intestinal phosphate and calcium 
absorption in vivo. Phosphate uptake in the duodenum (A) and jejunum (B) and ileum (C) was 
determined in vivo using buffer containing 10 mM phosphate. Calcium uptake in the duodenum 
(D), jejunum (E) and ileum (F) was determined using a buffer containing 100 mM calcium. 
Animals were maintained on a control (-●-) or iron deficient diet (-■-) for 2 weeks. A two-way 
ANOVA with Bonferroni multiple comparisons post-hoc test was used to compare differences 
between groups, *P<0.05, **P<0.01, ****P<0.0001 (n=4-8). 
Figure 3: Effect of diet-induced iron deficiency on NaPi-IIb mRNA and protein. RT-PCR was 
used to determine the effect of iron deficiency on NaPi-IIb mRNA in the duodenum and jejunum 
(A). Duplicate PCR reactions were performed for each sample and the mRNA expression of 
NaPi-IIb is given as the ratio of NaPi-IIb to β-actin. An unpaired t-test was used to compare 
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rats (B) and the effect of iron deficiency on jejunal NaPi-IIb protein levels (C) were quantified by 
western blotting of BBM vesicles prepared from the intestine of control and iron deficient animals. 
The bar graphs show the density of NaPi-IIb relative to β-actin, with results compared using an 
unpaired t-test (*P<0.05, n=4-5). 
Figure 4: Effect of diet-induced iron deficiency on the mRNA expression of transcellular 
calcium transporters in the small intestine. RT-PCR was used to determine the effect of iron 
deficiency on the mRNA expression of TRPV6 (A), calbindin D9K (B), PMCA-1b (C) and NCX-1 
(D) in the duodenum, jejunum and ileum. Duplicate PCR reactions were performed for each 
sample and the mRNA expression of each transporter is given as its ratio to β-actin. An unpaired 
t-test was used to compare differences between groups (*P<0.05, n=5-10).
Figure 5: Effect of diet-induced iron deficiency on the protein levels of transcellular 
calcium transporters in the small intestine. Representative western blot image and 
quantification of TRPV6 (A), calbindin D9K (B), PMCA-1b (C) and NCX-1 (D) protein level in the 
duodenum. The abundance of protein is given as the ratio of protein of interest band density to β-
actin, expressed in arbitrary units (a.u). An unpaired t-test was used to compare differences 
between groups (**P<0.01, n=6-8).
Figure 6: Effect of diet-induced iron deficiency on the mRNA expression of intestinal 
claudins. RT-PCR was used to determine the effect of iron deficiency on the mRNA expression 
of claudin 2 (A), claudin 3 (B), claudin 4 (C), claudin 7 (D), claudin 8 (E), claudin 12 (F) and 
claudin 15 (G) in the duodenum, jejunum and ileum. Duplicate PCR reactions were performed for 
each sample and the mRNA expression of each claudin is given as its ratio to β-actin. An 
unpaired t-test was used to compare differences between groups (*P<0.05, ***P<0.001, n=5-10)
Figure 7: Diet-induced iron deficiency increases claudin 3 protein levels in the duodenum. 
Representative western blot image and quantification of claudin 3 protein levels in the duodenum 
(A), jejunum (B) and ileum (C) of control and iron deficient animals. The abundance of claudin 3 
protein is given as the ratio of claudin 3 band density to β-actin, expressed in arbitrary units (a.u). 
An unpaired t-test was used to compare results between groups (*P<0.05, n=5-6).
Figure 8: Diet-induced iron deficiency increases claudin 2 protein levels in the duodenum. 
Representative western blot image and quantification of claudin 2 protein levels in the duodenum 
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protein is given as the ratio of claudin 2 band density to β-actin, expressed in arbitrary units (a.u). 
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Table 1. Effect of diet-induced iron deficiency on markers of iron status and 
animal weight.  
 
 Control Iron deficient 
Hematocrit (%) 42.38 ± 0.45 37.08 ± 0.75 *** 
Serum iron (µmol/L) 36.50 ± 2.82 9.22 ± 1.15 *** 
Serum UIBC (µg/dl) 357.20 ± 10.15 473.90 ± 8.13 **** 
Plasma ferritin (ng/ml) 224.40 ± 59.46 41.45 ± 10.78 * 
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Table 2. Effect of diet-induced iron deficiency on systemic calcium and 
phosphate regulators 
 
 Control Iron deficient 
Serum iFGF-23 (pg/ml) 571.50 ± 66.06 461.50 ± 34.86 
Serum cFGF-23 (pg/ml) 622.80 ± 84.35 543.70 ± 117.50 
Plasma intact PTH (pg/ml) 87.71 ± 17.25 78.12 ± 11.09 
Serum 1,25(OH)2D3 (fmol/L) 150.70 ± 7.84 144.00 ± 7.18 
Serum Phosphate (mmol/L) 3.48 ± 0.28 3.43 ± 0.11 
Serum Calcium (mmol/L) 2.04 ± 0.02 2.09 ± 0.04 
Urine Phosphate / Urine Creatinine 2.21 ± 0.15 2.09 ± 0.50 
Urine Phosphate excretion (mmol/16hrs) 0.198 ± 0.032 0.145 ± 0.007 
Urine Calcium / Urine Creatinine 0.20 ± 0.02 0.22 ± 0.02 
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